CymitQuimica logo
PI3K/Akt/mTOR Signaling

PI3K/Akt/mTOR Signaling

PI3K/Akt/mTOR signaling inhibitors are compounds that target the phosphoinositide 3-kinase (PI3K), Akt kinase, and mammalian target of rapamycin (mTOR) pathways. These pathways are critical regulators of cell growth, survival, metabolism, and autophagy, making them key targets in cancer research and metabolic disorders. Inhibiting these pathways can help to control tumor growth and proliferation, offering potential therapeutic strategies for various cancers and other diseases characterized by dysregulated cell signaling. At CymitQuimica, we offer a comprehensive selection of high-quality PI3K/Akt/mTOR inhibitors to support your research in oncology, cellular signaling, and metabolic diseases.

Subcategories of "PI3K/Akt/mTOR Signaling"

Show 2 more subcategories

Found 1038 products of "PI3K/Akt/mTOR Signaling"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • AZ14240475


    <p>AZ14240475 is a potent, selective, brain-penetrant inhibitor of EGFREx20Ins mutants (EGFREx20Ins mutants) with a pIC50 of 7.6, playing a significant role in cancer research.</p>
    Formula:C23H15ClF2N6O2
    Color and Shape:Solid
    Molecular weight:480.854
  • FAP-PI3KI1

    CAS:
    <p>FAP-PI3KI1: A FAP-targeted PI3K inhibitor reducing collagen synthesis in human IPF cells.</p>
    Formula:C52H48F4N10O12S3
    Color and Shape:Solid
    Molecular weight:1177.19
  • Timigutuzumab

    CAS:
    <p>Timigutuzumab (GEXMab73) is a humanized monoclonal antibody designed to target ErbB2, showing potential application in cancer research [1].</p>
    Color and Shape:Liquid
  • PROTAC EGFR degrader 11

    CAS:
    <p>PROTAC EGFR degrader 11 (Compound B71) is a PROTAC degrader targeting the epidermal growth factor receptor (EGFR), with a DC50 of less than 100 nM. It binds to CRBN-DDB1 with a Ki of 36 nM. This compound effectively degrades EGFR, focal adhesion kinase (FAK), and RSK1, and inhibits the proliferation of BaF3 wild-type and EGFR mutant cells, exhibiting an IC50 of less than 100 nM.</p>
    Formula:C49H64ClFN10O7S
    Color and Shape:Solid
    Molecular weight:991.61
  • EGFR T790M/L858R-IN-9


    <p>EGFRT790M/L858R-IN-9 (Compound 8) is an inhibitor targeting the EGFR-L858R/T790M mutations. It effectively inhibits the phosphorylation of the EGFR-L858R/T790M mutant kinase, demonstrating an IC50 value of 0.0064 µM. Additionally, EGFRT790M/L858R-IN-9 can suppress the proliferation of non-small cell lung cancer (NSCLC) cells, making it useful for cancer research.</p>
    Formula:C26H27N7O3S
    Color and Shape:Solid
    Molecular weight:517.603
  • PI5P4Ks-IN-2

    CAS:
    <p>PI5P4Ks-IN-2 inhibits PI5P4K isoforms α, β, γ, γ+ with IC50 &lt;4.3, &lt;4.6, 6.2, 0.32 µM, respectively.</p>
    Formula:C22H23N5
    Purity:98.36% - 99.02%
    Color and Shape:Soild
    Molecular weight:357.45
  • FDA-Approved Kinase Inhibitor Library


    <p>A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.</p>
    Color and Shape:Liquid
  • PF-06465603

    CAS:
    <p>PF-06465603 is a metabolite of PF-04691502, a highly potent and selective ATP competitive kinase inhibitor of class 1 PI3Ks and mTOR.</p>
    Formula:C22H25N5O5
    Color and Shape:Solid
    Molecular weight:439.46
  • Kinase Inhibitor Library


    <p>A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;</p>
    Color and Shape:Odour Solid
  • 4-Epidoxycycline

    CAS:
    <p>4-Epidoxycycline is a hepatic metabolite of the antibiotic doxycycline and lacks antibiotic properties in mice. In both in vitro assays and in vivo mouse models, 4-Epidoxycycline regulates HER2 gene expression similarly to doxycycline and exhibits comparable efficacy in tumor tissues, achieving over 95% tumor regression rates.</p>
    Formula:C22H24N2O8
    Color and Shape:Solid
    Molecular weight:444.44
  • Simotinib hydrochloride

    CAS:
    <p>Simotinib hydrochloride: selective oral EGFR inhibitor, IC50 19.9 nM, potent anticancer agent.</p>
    Formula:C25H27Cl2FN4O4
    Color and Shape:Solid
    Molecular weight:537.41
  • DP-C-4


    <p>DP-C-4 is a Cereblon-based dual PROTAC for simultaneous degradation of EGFR and PARP[1].</p>
    Color and Shape:Liquid
  • DNA Damage & Repair Compound Library


    <p>A unique collection of xnum DNA Damage &amp;amp; Repair related compounds for high throughput screening (HTS) and high content screening (HCS);</p>
    Color and Shape:Odour Solid
  • 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile

    CAS:
    <p>6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study</p>
    Formula:C9H6BrN3O
    Purity:99.81%
    Color and Shape:Solid
    Molecular weight:252.07
  • EGFR-IN-140


    <p>EGFR-IN-140 (Compound 31) is an inhibitor of EGFR, effectively targeting both wild-type EGFR and the EGFRL858R/T790M/C797S mutant, with Ki values of 0.95 nM and 2.1 nM, respectively. Additionally, it inhibits EGFRdel19/T790M/C797S in Ba/F3 cells with an IC50 of 56.9 nM and demonstrates antitumor activity in mouse models.</p>
    Formula:C27H37FN8O2
    Color and Shape:Solid
    Molecular weight:524.633
  • Tyrosine Kinase Inhibitor Library


    <p>A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related</p>
    Color and Shape:Odour Solid
  • 740 Y-P(TFA)


    <p>740 Y-P(TFA)(1236188-16-1 free base) (740YPDGFR(TFA)) is a potent and cell-permeable activator of PI3K.</p>
    Formula:C143H223F3N43O41PS3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:3384.73
  • MS9427

    CAS:
    <p>MS9427: PROTAC EGFR degrader, 7.1 nM (WT), 4.3 nM (L858R); targets mutant via UPS and autophagy; inhibits NSCLC cell growth; anticancer research.</p>
    Formula:C48H58ClFN8O12
    Color and Shape:Solid
    Molecular weight:993.47
  • Zenocutuzumab

    CAS:
    <p>Zenocutuzumab (MCLA-128) is a humanized antibody targeting HER2, used for research on tumors driven by NRG1 gene rearrangement.</p>
    Purity:97%
    Color and Shape:Liquid
  • EGFR-IN-81


    <p>EGFR-IN-81 (Compound 10i), an EGFR inhibitor, demonstrates potent activity by inhibiting EGFR WT and the L858R/T790M mutation at IC50 values of 4.38 nM and 5.69</p>
    Formula:C28H24F3N5O4
    Purity:98%
    Color and Shape:Solid
    Molecular weight:551.52